The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina

被引:12
|
作者
Ferrante, Daniel [1 ]
Konfino, Jonatan [1 ]
Mejia, Raul [2 ]
Coxson, Pamela [3 ]
Moran, Andrew [4 ]
Goldman, Lee [5 ]
Perez-Stable, Eliseo J. [3 ]
机构
[1] Minist Salud Nac, Buenos Aires, DF, Argentina
[2] Ctr Estudios Estado & Soc, Buenos Aires, DF, Argentina
[3] Univ Calif San Francisco, Dept Med, Div Med Gen Interna, San Francisco, CA USA
[4] Columbia Univ, Dept Med, Div Med Gen Interna, New York, NY USA
[5] Columbia Univ, Colegio Med & Cirujanos, New York, NY USA
关键词
Sodium; dietary; cardiovascular diseases; cost-benefit analysis; Argentina; CORONARY-HEART-DISEASE; BLOOD-PRESSURE; POLICY MODEL; RISK-FACTORS; MYOCARDIAL-INFARCTION; LATIN-AMERICAN; HYPERTENSION; SODIUM; STROKE; METAANALYSIS;
D O I
10.1590/S1020-49892012001000005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. Estimate the cost-utility ratio of an intervention to reduce dietary salt intake in people over the age of 35 in Argentina. Methods. The intervention consisted of reducing salt content in food by 5% to 25%. A simulation model was used to measure the impact of policies on heart disease in order to predict incidence, prevalence, mortality, and cost trends for heart and cerebrovascular disease in the population aged 35-84. The intervention modeled the impact and costs of a 3-gram reduction in dietary salt intake by reducing the amount of salt in processed food and salt added to food by the participants themselves over a 10-year period. Changes in event occurrence during this period and gains in quality-adjusted life years (QALY) were estimated in high-and low-impact scenarios. Results. The intervention generated a net savings of US$ 3 765 million and a gain of 656 657 QALYs in the high-impact scenario and a savings of US$ 2 080 million and 401 659 QALY in the low-impact scenario. The result would be reductions in the incidence of heart disease (24.1%), acute myocardial infarction (21.6%), and stroke (20.5%), as well as in mortality from heart disease (19.9%) and all causes (6.4%). Benefits were observed for all age groups and both genders. Conclusions. Implementing this strategy to reduce salt intake would produce a very positive health impact, both in QALY gains and savings in economic resources.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 41 条
  • [1] Reducing salt intake to prevent hypertension and cardiovascular disease
    He, Feng J.
    Campbell, Norm R. C.
    MacGregor, Graham A.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2012, 32 (04): : 293 - 300
  • [2] Aspirin for the primary prevention of cardiovascular disease in women - A cost-utility analysis
    Pignone, Michael
    Earnshaw, Stephanie
    Pletcher, Mark J.
    Tice, Jeffrey A.
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) : 290 - 295
  • [3] Reducing Salt Intake for Prevention of Cardiovascular Disease-Times Are Changing
    Stolarz-Skrzypek, Katarzyna
    Staessen, Jan A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2015, 22 (02) : 108 - 115
  • [4] The Cost-Effectiveness and Cost-Utility of Statin Drug for the Treatment of Patients with Cardiovascular Disease, A Systematic Review
    Eisavi, Mahmoud
    Mazaheri, Elaheh
    Rezapour, Aziz
    Vahedi, Sajad
    Hadian, Marziye
    Jafari, Abdosaleh
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2021, 12 (01)
  • [5] Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease
    Zhou, Ting
    Chen, Zhiyuan
    Li, Hongchao
    Xie, Feng
    MEDICAL DECISION MAKING, 2021, 41 (06) : 685 - 692
  • [6] Evaluation of health utility in trial-based cost-utility analyses for major cardiovascular disease: protocol for a systematic review
    Nakao, Yasuhisa
    Kawakami, Hiroshi
    Miyazaki, Shigehiro
    Saito, Makoto
    Luo, Yan
    Yamamoto, Kazumichi
    Yamaguchi, Osamu
    BMJ OPEN, 2023, 13 (05):
  • [7] The countries of the Americas are mobilizing to reduce hypertension and cardiovascular disease by reducing salt intake in the population
    Blanco-Metzler, Adriana
    Legetic, Branka
    Campbell, Norm R. C.
    ARCHIVOS LATINOAMERICANOS DE NUTRICION, 2010, 60 (01) : 5 - 6
  • [8] COST-UTILITY ANALYSIS OF LUNG CANCER SCREENING COMBINED WITH CARDIOVASCULAR DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE SCREENING
    Behr, C.
    Ijzerman, M.
    Kip, M. M. A.
    Vliegenthart, R.
    Koffijberg, H.
    VALUE IN HEALTH, 2022, 25 (12) : S75 - S75
  • [9] Cost-utility analysis of cardiovascular outpatient rehabilitation care and spa treatment care for patients with heart disease
    Ondřej Gajdoš
    Vojtěch Kamenský
    Kristýna Doskočilová
    Martina Caithamlová
    Ivana Kubátová
    Cost Effectiveness and Resource Allocation, 18
  • [10] A REVIEW OF CARDIOVASCULAR DISEASE HEALTH STATE UTILITIES REPORTED IN COST-UTILITY ANALYSES 2000-2010
    Thorat, T.
    Lin, P. J.
    Cangelosi, M. J.
    Neumann, P. J.
    VALUE IN HEALTH, 2013, 16 (03) : A33 - A34